您的位置: 首页 > 农业专利 > 详情页

Compositions and methods for treating beta-hemoglobinopathies
专利权人:
Calimmune, Inc.;Calimmune Australia Pty Ltd
发明人:
AHLERS, Jeffrey,BARTLETT, Jeffrey,LEE, Chi-Lin,RINGPIS, Gene-Errol Eugenio,SYMONDS, Geoffrey Phillip,YAN, Ming
申请号:
AU2018302098
公开号:
AU2018302098A1
申请日:
2018.07.17
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
The present disclosure provides expression vectors comprising at least two nucleic acid sequences, namely a nucleic acid sequence encoding an anti-HPRT RNAi, and a nucleic acid sequence encoding a gamma globin gene. In some embodiments, the viral vector is a self-inactivating lentiviral vector. In some embodiments, the gamma-globin gene is used to genetically correct sickle cell disease or β-thalassemia or to reduce symptoms thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充